CCEL has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
This is the expense the company spent on research and development. Cryo-Cell International, Inc.'s research and development for the three months ended in Feb. 2014 was $0.01 Mil. Its research and development for the trailing twelve months (TTM) ended in Feb. 2014 was $0.04 Mil.
This is the expense the company spent on research and development.
Cryo-Cell International, Inc. Research & Development for the trailing twelve months (TTM) ended in Feb. 2014 was 0.007 (May. 2013 ) + 0.008 (Aug. 2013 ) + 0.01 (Nov. 2013 ) + 0.014 (Feb. 2014 ) = $0.04 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
If competitive advantage is created by a patent or tech advantage, at some point it will disappear.
High R&D usually dictates high SG&A which threatens the competitive advantage.
Cryo-Cell International, Inc. Annual Data
|Research & Development||0.08||0.03||0.49||0.55||0.19||0.10||0.13||0.18||0.11||0.04|
Cryo-Cell International, Inc. Quarterly Data
|Research & Development||0.02||0.02||0.01||0.07||0.02||0.01||0.01||0.01||0.01||0.01|